Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06868485 |
| Consolidated Lead Sponsor | Wayshine Biopharm |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 40 participants (ESTIMATED) |
| Registered Start Date | 2025-08-18 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Cleveland Clinic Florida | Weston, FL | Open Hospital Dossier -> |
| Karmanos Cancer Institute | Detroit, MI | Open Hospital Dossier -> |
| Cleveland Clinic | Cleveland, OH | Open Hospital Dossier -> |
| UPMC Hillman Cancer Center | Pittsburgh, PA | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.